Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Blockade by antiarrhythmic drugs of glibenclamide-sensitive K+ channels in Xenopus oocytes.
Sakuta H
,
Okamoto K
,
Watanabe Y
.
???displayArticle.abstract???
1. The outward K+ current induced by KRN2391 (K+ channel opener) in Xenopus oocytes is blocked by glibenclamide. We have investigated the effects of various classes (I-IV) of antiarrhythmic drugs on this KRN2391-induced response. 2. All class I antiarrhythmic drugs (Na+ channel blockers) tested concentration-dependently suppressed KRN2391-induced responses with the rank order of potency (IC50 in microM), disopyramide (17.8) > aprindine (29.5) > propafenone (63.1) > ajmaline (145) > quinidine (151). Flecainide, SUN1165, lignocaine, mexiletine and procainamide were much less potent (IC50, 450- > 1000 microM) than quinidine. 3. The class II antiarrhythmic drugs (beta-blockers), timolol, (-)- and (+/-)- propranolol, and (+)- propranolol (a non-beta-blocker) inhibited KRN2391-induced K+ currents in a concentration-dependent manner with values for IC50 (microM) of 79, 131, 151 and 129, respectively, whilst butoxamine, oxprenolol, alprenolol, pindolol, nadolol, metoprolol and acebutolol were either weak (IC50, 300 microM-600 microM) or virtually inactive (IC50, > 1000 microM). 4. The class III antiarrhythmic drugs, amiodarone and (+)-sotalol scarcely affected KRN2391 responses. 5. All class IV drugs (Ca2+ antagonists) tested suppressed KRN2391-induced responses in a concentration-dependent manner with an IC50 of 6.3 microM for bepridil, 38 microM for prenylamine, 85 microM for verapamil and 135 microM for diltiazem. 6. In conclusion, antiarrhythmic drugs of classes I, II and IV potently blocked glibenclamide-sensitive K+ channels in Xenopus oocytes.
Ashcroft,
Glucose induces closure of single potassium channels in isolated rat pancreatic beta-cells.
, Pubmed
Ashcroft,
Glucose induces closure of single potassium channels in isolated rat pancreatic beta-cells.
,
Pubmed
Ashford,
Adenosine-5'-triphosphate-sensitive ion channels in neonatal rat cultured central neurones.
1988,
Pubmed
Balser,
Suppression of time-dependent outward current in guinea pig ventricular myocytes. Actions of quinidine and amiodarone.
1991,
Pubmed
Barron,
Comparative antiarrhythmic and electrophysiological effects of drugs known to inhibit calmodulin (TFP, W7 and bepridil).
1986,
Pubmed
Carmeliet,
Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibers.
1985,
Pubmed
Cook,
Intracellular ATP directly blocks K+ channels in pancreatic B-cells.
,
Pubmed
Epstein,
Interaction of calcium antagonists with cyclic AMP phosphodiesterases and calmodulin.
1982,
Pubmed
Escande,
The potassium channel opener cromakalim (BRL 34915) activates ATP-dependent K+ channels in isolated cardiac myocytes.
1988,
Pubmed
Fleckenstein,
Historical overview. The calcium channel of the heart.
1988,
Pubmed
Haworth,
Inhibition of ATP-sensitive potassium channels of adult rat heart cells by antiarrhythmic drugs.
1989,
Pubmed
Hidaka,
Calcium-regulated modulator protein interacting agents inhibit smooth muscle calcium-stimulated protein kinase and ATPase.
1980,
Pubmed
Hidaka,
Activity-structure relationship of calmodulin antagonists, Naphthalenesulfonamide derivatives.
1981,
Pubmed
Honoré,
Hormone-regulated K+ channels in follicle-enclosed oocytes are activated by vasorelaxing K+ channel openers and blocked by antidiabetic sulfonylureas.
1991,
Pubmed
,
Xenbase
Honoré,
Two different types of channels are targets for potassium channel openers in Xenopus oocytes.
1991,
Pubmed
,
Xenbase
Itoh,
Effects on calmodulin of bepridil, an antianginal agent.
1984,
Pubmed
Kantor,
Reduction of ischemic K+ loss and arrhythmias in rat hearts. Effect of glibenclamide, a sulfonylurea.
1990,
Pubmed
Kashiwabara,
Characteristics of KRN2391, a novel vasodilator, compared with those of cromakalim, pinacidil and nifedipine in rat aorta.
1991,
Pubmed
Marshall,
Effects of antiarrhythmic drugs on ventricular fibrillation thresholds of normal and ischaemic myocardium in the anaesthetized rat.
1983,
Pubmed
Muto,
Effects of local anesthetics on calmodulin-dependent guanylate cyclase in the plasma membrane of Tetrahymena pyriformis.
1983,
Pubmed
Noma,
ATP-regulated K+ channels in cardiac muscle.
,
Pubmed
Notsu,
Blockade of the ATP-sensitive K+ channel by 5-hydroxydecanoate in guinea pig ventricular myocytes.
1992,
Pubmed
Pang,
Uptake of calcium antagonistic drugs into muscles as related to their lipid solubilities.
1984,
Pubmed
Pruett,
Propranolol effects on membrane repolarization time in isolated canine Purkinje fibers: threshold tissue content and the influence of exposure time.
1980,
Pubmed
Sakuta,
Inactivation of glibenclamide-sensitive K+ channels in Xenopus oocytes by various calmodulin antagonists.
1992,
Pubmed
,
Xenbase
Sanguinetti,
Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents.
1990,
Pubmed
Singh,
Second-generation calcium antagonists: search for greater selectivity and versatility.
1985,
Pubmed
Spruce,
Voltage-dependent ATP-sensitive potassium channels of skeletal muscle membrane.
,
Pubmed
Sturgess,
The sulphonylurea receptor may be an ATP-sensitive potassium channel.
1985,
Pubmed
Taggart,
Class III action of beta-blocking agents.
1984,
Pubmed
Vaughan Williams,
A classification of antiarrhythmic actions reassessed after a decade of new drugs.
1984,
Pubmed
Volpi,
Local anesthetics, mepacrine, and propranolol are antagonists of calmodulin.
1981,
Pubmed
Winslow,
The effects of bepridil compared with calcium antagonists on rat and rabbit aorta.
1986,
Pubmed
Wolleben,
Influence of ATP-sensitive potassium channel modulators on ischemia-induced fibrillation in isolated rat hearts.
1989,
Pubmed
Woosley,
Antiarrhythmic drugs.
1991,
Pubmed
Zimmer,
Differentiation of the drug-binding sites of calmodulin.
1987,
Pubmed
